Key facts
- It has raised $42.6M across 1 recorded rounds; the latest was Early Stage VC ($7.6M) in Jan 2019.
- Notable investors include BDC Capital, MaRS Investment Accelerator Fund, Participatiemaatschappij Vlaanderen, iGan Partners, Veddis — 14 tracked in total.
- Exact Imaging has filed 3 Form Ds with the SEC, most recently Nov 2019 ($244K sold to 11 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Exact Imaging
Funding rounds
1 roundsAbout Exact Imaging
Developer of high-resolution micro-ultrasound systems designed for real-time prostate imaging and biopsy guidance. The company's platform offers enhanced imaging clarity, integrates with existing clinical workflows, and uses targeted biopsy protocols, enabling urologists and oncologists to improve prostate cancer diagnostics with greater access and reduced costs.
- Sector
- Healthcare
- HQ
- Markham, Canada
- Employees
- 40
- Website
- exactimaging.com/
- Ownership
- Privately Held (backing)
Exact Imaging doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Exact Imaging shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Exact Imaging in its N-PORT filings yet. We sweep new filings monthly.